據報港交所(00388.HK)就SPAC諮詢結果研究彈性處理三項要求
港交所(00388.HK)就推行特殊目的收購公司(SPAC)上市機制徵詢市場意見,諮詢期已於10月31日結束。據《星島日報》報道,港交所正根據諮詢結果,研究是否對專業投資者人數、獨立第三方投資者(PIPE)投資佔比,及贖回股份與反對票合併捆綁共三項要求作出彈性處理。
報道引述業界意見指,期望交易所釐清本港引入SPAC的原意是「人有我有」,抑或希望吸引更多項目以SPAC形式來港上市,普遍樂見港交所可能對上市框架要求鬆綁。
港交所提出的諮詢文件要求,SPAC應至少有75名專業投資者參與,當中有30名為機構專業投資者,並強制外來獨立PIPE投資須佔繼承公司預期市值至少25%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.